Quality of Postoperative Recovery in Total Intravenous Anesthesia between Remimazolam and Propofol for Intraoperative Neurophysiological Monitoring: A Prospective Double-Blind Randomized Controlled Trial
Open Access
- 2 April 2024
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (4) , 382
Abstract
This study compared the overall postoperative recovery of patients who underwent total intravenous anesthesia with remimazolam or propofol, using the Quality of Recovery-15 questionnaire (QoR-15). Seventy-two patients who underwent spine surgery with intraoperative neurophysiological monitoring (IONM) were randomly categorized into the remimazolam group (group R) or propofol group (group P). On the first postoperative day, the QoR-15 scores for groups P and R were 114 and 112, respectively, indicating no significant difference (p = 0.691). Similarly, group–time interaction effects on QoR-15 scores were not significantly different. In the post-anesthesia care unit, the pain intensity at rest was notably higher in group P than in group R (3.0 [0.0] vs. 2.8 [0.5], respectively, p = 0.009). Although the intraoperative consumption of remifentanil was higher in group R (1452.4 µg vs. 2066.8 µg, respectively, p < 0.001), the intraoperative use of vasopressors was lower in group R (1705.6 µg vs. 286.1 µg, respectively, p < 0.001) compared to group P. Group R exhibited significantly lower variability in mean blood pressure over time compared to group P. Remimazolam was viewed as a promising intravenous agent for general anesthesia, showing potential to replace propofol in spine surgery with IONM, considering both recovery quality and intraoperative hemodynamic stability.Keywords
This publication has 36 references indexed in Scilit:
- Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairmentBritish Journal of Anaesthesia, 2021
- Current status of perioperative hypnotics, role of benzodiazepines, and the case for remimazolam: a narrative reviewBritish Journal of Anaesthesia, 2021
- Validation and clinical utility of the Korean version of the Quality of Recovery-15 with enhanced recovery after surgery: a prospective observational cohort studyBritish Journal of Anaesthesia, 2020
- Target-controlled-infusion models for remifentanil dosing consistent with approved recommendationsBritish Journal of Anaesthesia, 2020
- Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!!Journal of Anesthesia, 2020
- Time‐to‐Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General AnesthesiaThe Journal of Clinical Pharmacology, 2020
- Clinical Pharmacokinetics and Pharmacodynamics of PropofolClinical Pharmacokinetics, 2018
- Systematic review of the QoR-15 score, a patient- reported outcome measure measuring quality of recovery after surgery and anaesthesiaBritish Journal of Anaesthesia, 2018
- The importance of postoperative quality of recovery: influences, assessment, and clinical and prognostic implicationsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2015
- The pathophysiology of propofol infusion syndrome: a simple name for a complex syndromeIntensive Care Medicine, 2003